Clinical Trials Browser

Completed × Osteosarcoma × cabozantinib × Clear all

NCT04661852 2023-02-15

Cabozantinib With Topotecan-Cyclophosphamide

Phase 1 Completed

Sarcoma, Ewing, Osteosarcoma